Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
60 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Liverpool, Australia
Recruiting - Research Site
Melbourne, Australia
Recruiting
- Research Site
Edmonton, Alberta, Canada
Recruiting - Research Site
London, Ontario, Canada
Recruiting - Research Site
Toronto, Ontario, Canada
Recruiting - Research Site
Montreal, Quebec, Canada
Recruiting - Research Site
Montreal, Quebec, Canada
Recruiting
- Research Site
Chengdu, China
Recruiting - Research Site
Chongqing, China
Recruiting - Research Site
Guangzhou, China
Recruiting - Research Site
Guangzhou, China
Recruiting - Research Site
Jinan, China
Recruiting - Research Site
Xi'an, China
Recruiting - Research Site
Zhengzhou, China
Recruiting
- Research Site
Berlin, Germany
Recruiting - Research Site
Essen, Germany
Not, yet, recruiting - Research Site
Freiburg im Breisgau, Germany
Not, yet, recruiting - Research Site
Hanover, Germany
Recruiting - Research Site
Leipzig, Germany
Recruiting - Research Site
Mannheim, Germany
Recruiting - Research Site
Regensburg, Germany
Recruiting
- Research Site
Haifa, Israel
Recruiting - Research Site
Ramat Gan, Israel
Recruiting
- Research Site
Hidaka-shi, Japan
Recruiting - Research Site
Kashiwa, Japan
Recruiting - Research Site
Kōtoku, Japan
Recruiting - Research Site
Sunto-gun, Japan
Recruiting - Research Site
Tokyo, Japan
Recruiting
- Research Site
Seoul, South Korea
Recruiting - Research Site
Seoul, South Korea
Recruiting
- Research Site
Barcelona, Spain
Recruiting - Research Site
Madrid, Spain
Recruiting - Research Site
Madrid, Spain
Recruiting - Research Site
Málaga, Spain
Recruiting
- Research Site
Taichung, Taiwan
Recruiting - Research Site
Tainan, Taiwan
Recruiting - Research Site
Taipei, Taiwan
Recruiting - Research Site
Taipei, Taiwan
Recruiting
- Research Site
Ankara, Turkey (Türkiye)
Recruiting - Research Site
Ankara, Turkey (Türkiye)
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jun 2023
- Primary completion
- 6 Jan 2028
- Completion
- 6 Jan 2028
- Last update posted
- 3 Jun 2026
- Registered enrollment
- 506
- Registry id
- NCT05797168
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.